Other publication

Targeting CD39 with a first-in-class inhibitory antibody prevents ATP processing and increases T-cell activation

Authors: Lerner AG, Kovalenko M, Welch M, Dela Cruz T, Jones J, Wong C, Spatola B, Eberhardt M, Wong A, Fung W, Lagpacan L, Losenkova K, Yegutkin G, Soros V, Corbin J, Beers C, Moesta AK, Moesta AK

Publisher: AMER ASSOC CANCER RESEARCH

Publication year: 2019

Journal: Cancer Research

Journal name in source: CANCER RESEARCH

Journal acronym: CANCER RES

Volume: 79

Issue: 13 Suppl.

Number of pages: 2

ISSN: 0008-5472

DOI: https://doi.org/10.1158/1538-7445.AM2019-5012